CLINICAL_TRIALS
trial_result
· 2020-01-30
Clinical Trial Update: Belatacept Post Depletional Repopulation to Facilitate Tolerance [Phase 2]
Summary
Phase 2 trial investigating belatacept post depletional repopulation aimed at facilitating transplant tolerance; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allan D Kirk, MD, PhD | Conditions: Organ Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2020-01-30